Sure looks like it with 15m shares traded today; about 5X normal is it? And that $500K as we know is low-cost generic chicken feed compared to what LL would cut into their profits with approval. BP and well-placed trolls, hack writers and whomever else behind the scenes that can swing an ax seem to be working frantically in concert to hold the LL monster down, aiming to keep it from uplisting it would appear is the short term goal. I've never seen so much resistance and credibility assassination directed at a company that has so much short and long term potential. A few years back I was invested in Titan Pharm who had a subcutaneously implanted form of buprenorphrine, to replace suboxone which was being abused badly in pill form. While Renckitt Benhiser, the owner of subox was being "hand-held thru the development/approval process by the FDA" according to many people smarter than me, in an effort to get their oral film approved at the same time, small bio Titan always seemed to have their concerns resolved the slowest, even getting a CRL on their first PDUFA date before finally getting approval after a subsequent trial. It seemed really odd in that RB's film was still as easily abused as their pill, while Titan's product was impossible to abuse as the opioid epidemic raged on. But even those detours and obstacles provided by BP/FDA and an occasional hit piece by tiny little Atom F. who may have been seeking alpha bits back then, were nothing compared to the onslaught of negative media and the literal black hole absence of other media coverage that CytoDyn endures today. Titan went thru uplist to NASDAQ as well and it went smoothly; the SP remained constant to its value thruout that and the last few clinical trials and never got hammered so relentlessly at inopportune times like we are getting here, to the point our pps chart looks more like a pogostick ride with super ball rubber caps on the bottom. This is nuts.